Screener
Royalty Pharma RPRX Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's invested capital?
- Royalty Pharma (RPRX) reported invested capital of $17.94B in Q2 2026.
- How has Royalty Pharma's invested capital changed year-over-year?
- Royalty Pharma's invested capital increased by 6.2% year-over-year, from $16.89B to $17.94B.
- What is the long-term trend for Royalty Pharma's invested capital?
- Over 5 years (2020 to 2025), Royalty Pharma's invested capital has grown at a 4.2% compound annual growth rate (CAGR), from $14.7B to $18.07B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Royalty Pharma's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude